Table 1.
Clinical findings of PBL of the small intestine
| Case | sex/Age (years) | initial location | CD4 | CD20 | CD79a | CD56 | CD138 | ENA | EBER-1 | HHV-8 | κ | λ | treatement | OS (months) | Outcome | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F/75 | cecum | - | - | - | - | + | NA | - | NA | + | - | unknown | unknown | unknown | [1] |
| 2 | M/55 | small intestine | NA | - | + | - | + | NA | - | NA | + | - | CHOP | 1.5 | dead | [4] |
| 3 | M60 | jejunal | NA | - | + | - | - | + | - | NA | - | + | CHOP | 24 | alive | [5] |
| 4 | F/65 | duodenal jejunal1 | - | - | + | + | + | + | + | - | - | + | none | 3.0 | dead | present |
Abbreviations: CHOP, cyclophosphamide, doxorubicine, vincristine, and prednisone; F, female; M, male; NA, not available; OS, overall survival.